In this episode of Drive Time from Iantrek, Carey Kelson speaks with Dr. Paul Singh and Dr. Christine Funke about AlloFlo™ Uveo adoption, patient selection, and working in the uveoscleral space. They discuss why the post-MIGS treatment gap matters, which data points resonate with peers, and how AlloFlo has changed their approach to glaucoma care. Their message to the field team is clear: meet each surgeon where they are, identify the barrier, and help them build confidence with the right support.

Show Notes
0:59 — Carey Kelson introduces Dr. Paul Singh and Dr. Christine Funke
1:39 — How both surgeons became involved with Iantrek and AlloFlo™ Uveo
6:29 — Addressing surgeon hesitation around the uveoscleral space
9:00 — CREST data, IOP reduction, medication reduction, and safety discussion
15:27 — Practical guidance for new users: patient selection, cleft creation, and surgeon support

Credits
Host: Carey Kelson, Vice President of Market Development
Guest: Dr. Paul Singh and Dr. Christine Funke
Production: Schaefer Advertising Co.

For internal use only.